Akiri et al reported that approximately 50% of human NSCLC cell lines exhibit excessive activation of the Wnt/β-Catenin signalling pathway43, and CTNNB1 was found to be expressed in 51% of resected LUAD tumor samples45. The gene discussed is CTNNB1; the disease is non-small cell lung carcinoma.